Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK).
Fopp M, Fey MF, Bacchi M, Cavalli F, Gmuer J, Jacky E, Schmid L, Tichelli A, Tobler A, Tschopp L, Von Fliedner V, Gratwohl A. Fopp M, et al. Among authors: tichelli a. Ann Oncol. 1997 Mar;8(3):251-7. doi: 10.1023/a:1008267904952. Ann Oncol. 1997. PMID: 9137794 Free article. Clinical Trial.
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK).
Wernli M, Tichelli A, von Fliedner V, Brun del Re G, Chapuis B, Fey MF, Fopp M, Gmür J, Grob JP, Jacky E, et al. Wernli M, et al. Among authors: tichelli a. Br J Haematol. 1994 May;87(1):39-43. doi: 10.1111/j.1365-2141.1994.tb04867.x. Br J Haematol. 1994. PMID: 7947254 Clinical Trial.
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).
Betticher DC, Ratschiller D, Hsu Schmitz SF, von Rohr A, Hess U, Zulian G, Wernli M, Tichelli A, Tobler A, Fey MF, Cerny T. Betticher DC, et al. Among authors: tichelli a. Ann Oncol. 1998 Jul;9(7):721-6. doi: 10.1023/a:1008273131598. Ann Oncol. 1998. PMID: 9739437 Free article. Clinical Trial.
MTS1 expression and prognosis in acute myeloid leukemia.
Rochlitz CF, Lohri A, Sasse-Roth G, van Hille B, Reuter J, Tichelli A, Bacchi M, Fopp M, Fey MF, Herrmann R. Rochlitz CF, et al. Among authors: tichelli a. Ann Hematol. 1997 Oct;75(4):141-4. doi: 10.1007/s002770050331. Ann Hematol. 1997. PMID: 9402846
Concomitant hairy cell and acute myeloid leukemia.
Rimner T, Went P, Tichelli A, Gratwohl A. Rimner T, et al. Among authors: tichelli a. Eur J Haematol. 2006 Jan;76(1):86-8. doi: 10.1111/j.0902-4441.0000.t01-1-EJH2356.x. Eur J Haematol. 2006. PMID: 16343277
372 results